Whole Slide Imaging System Market

Whole Slide Imaging System Market Outlook (2024 to 2034)

Global sales of whole slide imaging systems are estimated at US$ 446.5 million in 2024 and have been analyzed to climb to US$ 1.08 billion by the end of 2034. The whole slide imaging system market has been forecasted to increase at 9.2% CAGR from 2024 to 2034. Advancements in digital pathology and the growing acceptance of digital imaging solutions in healthcare are key factors driving market growth.

Pathologists are utilizing whole slide imaging systems to scan complete tissue samples for examination, allowing high-resolution pictures to be viewed, saved, and shared remotely. This technology provides advantages such as increased workflow efficiency, improved cooperation among healthcare experts, and better preservation of precious samples.

• Recognizing the rapid advancements in clinical applications for whole slide imaging and digital pathology, the College of American Pathologists (CAP) collaborated in May 2021 with the American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API) to revise guidelines validating whole slide imaging for diagnostic purposes in pathology.

Increasing prevalence of chronic illnesses and the growing demand for precise diagnostic solutions are contributing to whole slide imaging system market growth.

Key Market Growth Drivers

• Technological advancements in digital pathology, such as enhanced imaging resolution, speed, and automation, are driving the development of whole slide imaging (WSI) systems.
• Advancements are enhancing the efficiency and accuracy of diagnostic operations, a key trend in the whole slide imaging system market, leading to a growing demand for digital imaging systems.
• WSI systems enable pathologists to evaluate tissue samples with greater accuracy and efficiency, thereby addressing the growing need for advanced diagnostic solutions.
• Rising popularity of telemedicine and remote healthcare services is boosting the demand for remote pathology solutions.
• Using whole slide imaging systems, pathologists can examine and interpret digital slides remotely, facilitating telepathology consultations and improving access to pathology expertise in underserved areas.
• Whole slide imaging systems enhance pathology procedures by digitizing entire tissue samples and automating image analysis, thus improving workflow efficiency, reducing turnaround times, and increasing laboratory throughput, which is driving demand in pathology laboratories.
• Ongoing research and development efforts aimed at enhancing WSI system capabilities, including the integration of artificial intelligence (AI) and machine learning algorithms, are propelling market growth. These technologies support automated image analysis, pattern recognition, and predictive modeling, thereby enhancing the diagnostic capabilities of WSI systems.
• Rising prevalence of chronic illnesses such as cancer, cardiovascular disease, and infectious diseases is necessitating precise and early pathology diagnosis, fueling the expansion of the whole slide imaging system market size.

Report Attribute	Detail
Whole Slide Imaging System Market Size (2024E)	US$ 446.5 Million
Forecasted Market Value (2034F)	US$ 1.08 Billion
Global Market Growth Rate (2024 to 2034)	9.2% CAGR
North America Market Share (2024E)	59.8%
East Asia Market Value (2024E)	US$ 110 Million
Sales of Scanners (2034F)	US$ 817.4 Million
Research Centers Segment Value (2034F)	US$ 604.7 Million
Key Companies Profiled	Hamamatsu Photonics K.K.; Roche Holding AG; NanoString Technologies; Indica Labs; Sakura Finetek; Danaher Corporation; Ventana Medical Systems, Inc.; Olympus Corporation; Leica Biosystems Nussloch GmbH; PerkinElmer, Inc.; DigiPath; 3DHISTECH Ltd.

How Does Integration of Whole Slide Imaging Devices Enhance Diagnostic Accuracy?

“WSI Devices Providing High-Resolution Images for Accurate Diagnoses”

Growing acceptance of precision medicine is boosting demand for advanced diagnostic technologies such as whole slide imaging (WSI) devices. Precision medicine focuses on tailoring medical treatments and interventions to individual patient characteristics, including genetics, lifestyle, and environmental factors. WSI systems are vital in this approach because they enable the detailed examination of tissue samples at the cellular level.

By digitizing entire tissue slides and providing high-resolution imaging, WSI systems assist pathologists in diagnosing and characterizing illnesses with greater accuracy. This capability aligns perfectly with the goals of precision medicine, allowing healthcare providers to customize treatment plans based on each patient's unique attributes, leading to improved clinical outcomes and care. Consequently, the adoption of WSI systems is becoming essential for advancing precision medicine initiatives in clinical practice.

What is Impeding Adoption of Whole Slide Imaging Systems?

“incompatibility between WSI Technologies and Existing LIS or EHR Systems”

Connectivity issues pose a significant challenge when integrating whole slide imaging (WSI) technologies with existing laboratory information systems (LIS) or electronic health record (EHR) systems. System incompatibility hinders the seamless exchange of digital pathology data, disrupting workflow integration and compromising operational efficiency. Pathologists and other healthcare professionals depend on integrated systems for quick access to patient data and pathology reports; any interruption in data exchange impacts diagnostic processes and patient outcomes.

Country-wise Insights

In 2024, North America is estimated to lead with 59.8% of the global whole slide imaging system market share. The East Asia market is evaluated to expand at a significant CAGR of 12.3% during the projection period (2024 to 2034).

What Positions the United States at the Forefront of Digital Pathology Innovations?

“Advancements in Imaging Technology, Software Algorithms, and Automation”

Attribute	United States
Market Value (2024E)	US$ 238 Million
Growth Rate (2024 to 2034)	8.6% CAGR
Projected Value (2034F)	US$ 545 Million

Advancements in digital pathology are positioning the United States at the forefront of the field's innovations. Ongoing progress in imaging technology, software algorithms, and automation is transforming the capabilities of whole slide imaging (WSI) systems. These advancements lead to enhanced image quality, faster scanning rates, and more accurate image processing, making WSI systems crucial tools in pathology laboratories and healthcare institutions nationwide.

Improved capabilities and performance of WSI systems are enabling more efficient and precise pathology diagnoses, leading to widespread acceptance and integration into clinical practice. Consequently, digital pathology is becoming a vital component of modern healthcare delivery in the United States, contributing to improved patient care and outcomes. These are key whole slide imaging system market trends that market players must capitalize on.

What is Driving Use of Whole Slide Imaging Systems in Japan?

“Increasing Need for Telepathology Boosting Demand for WSI Systems”

Attribute	Japan
Market Value (2024E)	US$ 26 Million
Growth Rate (2024 to 2034)	12.8% CAGR
Projected Value (2034F)	US$ 85 Million

Telepathology is gaining popularity in Japan due to the advantages of remote access to digital pathology slides provided by whole slide imaging (WSI) systems. Pathologists can evaluate and interpret digital slides remotely via telepathology, enhancing collaboration and facilitating consultations among healthcare providers. WSI systems are crucial in telepathology because they digitize entire tissue samples at high resolution, enabling pathologists to examine intricate cellular structures remotely.

This capability not only improves diagnostic accuracy and efficiency but also allows healthcare professionals to extend pathology services to underserved areas and increase access to expert opinions. Consequently, medical professionals in Japan view WSI systems as essential for advancing telepathology capabilities and enhancing patient care.

Category-wise Insights

Based on application, the market is segmented into telepathology, cytopathology, immunohistochemistry, and hematopathology. The telepathology segment holds a significant worldwide market share as WSI systems enable pathologists to remotely examine and analyze high-resolution digital pictures of whole tissue samples, facilitating collaboration and consultation among specialists from various locations.

Why are Scanners Essential Components in Digital Pathology?

“Scanners Facilitating Conversion of Glass Slides into Digital Images”

Attribute	Scanners
Segment Value (2024E)	US$ 352.8 Million
Growth Rate (2024 to 2034)	8.8% CAGR
Projected Value (2034F)	US$ 817.4 Million

Scanners are in great demand because they are essential for digitizing glass slides and producing high-resolution digital images. As the primary input device in the digital pathology process, scanners are crucial for remote access, storage, and analysis of pathology slides.

With the growing adoption of digital pathology solutions in the healthcare sector, demand for scanners is increasing to support the transition from traditional microscopy to digital imaging. Advancements in scanner technology, including higher image resolution, speed, and automation, are driving this demand as healthcare practitioners aim to enhance diagnostic accuracy, workflow efficiency, and patient care.

Why is Need for Whole Slide Imaging Systems High in Research Centers?

“WSI Systems Facilitating Collaboration and Remote Sharing of Digital Slides among Researchers”

Attribute	Research Centers
Segment Value (2024E)	US$ 273.5 Million
Growth Rate (2024 to 2034)	8.3% CAGR
Projected Value (2034F)	US$ 604.7 Million

Demand for whole slide imaging (WSI) systems is rising in research centers due to their crucial role in medical research, drug development, and disease understanding, which often requires thorough histopathological examination of tissue samples. WSI systems empower researchers to scan entire tissue slides at high resolution, facilitating in-depth study and collaboration among peers. WSI technology provides remote access to digital slides, enabling academics to exchange and collaborate on data more efficiently.

Competitive Landscape

Key players in the whole slide imaging system market are focusing on product innovation and differentiation to offer advanced features such as increased image resolution, quicker scanning rates, and enhanced automation capabilities to meet the changing demands of healthcare professionals. Furthermore, strategic agreements and collaborations with healthcare institutions, research organizations, and technology suppliers assist in broadening market reach and client base.

• In May 2024, Indica Labs, a market leader in AI-powered digital pathology solutions, and Hamamatsu Photonics K.K., a pioneer in whole slide imaging systems, announced that the United States Food and Drug Administration (FDA) had granted Indica Labs a 510(k) clearance for HALO AP Dx, an enterprise digital pathology platform. HALO AP Dx is used for the main diagnosis of surgical pathology slides made from formalin-fixed paraffin-embedded (FFPE) tissue and scanned with the NanoZoomer S360MD Slide scanner1. The FDA's 510(k) approval extends an existing relationship between Indica Labs and Hamamatsu Photonics K.K.
• In April 2024, Standard BioTools Inc. released new solutions for the Hyperion XTi Imaging System, bringing automation and flexibility to the Imaging Mass Cytometry process. The company's mission is to accelerate discoveries in human health.
• In September 2023, Evident announced a collaboration with Corista, Sakura Finetek USA, and Visiopharm to provide an automated, end-to-end workflow solution for pathology in the United States. The scientific leaders are expected to combine their technology to improve the process of staining, photographing, and analyzing full-slide pictures while maintaining the cooperation and management required in today's high-volume laboratory.
• In June 2022, HistoWiz, Inc., an internationally recognized digital histology service provider, and Pramana, Inc., an AI-enabled health tech business revolutionizing the pathology sector, announced a collaboration to deliver high-throughput whole slide imaging (WSI) and image management to enterprises of all sizes.

Fact.MR provides detailed information about the price points of key manufacturers of whole slide imaging systems positioned across the world, sales growth, production capacity, and speculative technological expansion, in this new market report.

Segmentation of Whole Slide Imaging System Market Research

• By Component :

  • Scanners
  • Services

• By Application :

  • Telepathology
  • Cytopathology
  • Immunohistochemistry
  • Hematopathology

• By End User :

  • Hospitals
  • Diagnostic Laboratories
  • Research Centers

• By Region :

  • North America
  • Western Europe
  • Eastern Europe
  • Latin America
  • East Asia
  • South Asia & Pacific
  • Middle East & Africa